Zobrazeno 1 - 10
of 2 823
pro vyhledávání: '"Ardavanis, A."'
Autor:
Yang, JaeWon, Ardavanis, Kyle S., Slack, Katherine E., Fernando, Navin D., Della Valle, Craig J., Hernandez, Nicholas M.
Publikováno v:
In The Journal of Arthroplasty May 2024 39(5):1184-1190
Autor:
Ardavanis, Kimon1 kimon.ardavanis@me.gspoffshore.com, Nabergoj, Radoslav2 radoslav.nabergoj@nasdispds.com, Mauro, Francesco3 f.mauro@tudelft.nl
Publikováno v:
Brodogradnja. 2022, Vol. 73 Issue 4, p1-11. 11p.
Autor:
Dimitra Galiti, Helena Linardou, Sofia Agelaki, Athanasios Karampeazis, Nikolaos Tsoukalas, Amanda Psyrri, Michalis Karamouzis, Konstantinos N. Syrigos, Alexandros Ardavanis, Ilias Athanasiadis, Eleni Arvanitou, Stavroula Sgourou, Anastasia Mala, Christos Vallilas, Ioannis Boukovinas
Publikováno v:
Current Oncology, Vol 30, Iss 8, Pp 7608-7619 (2023)
Introduction: The increasing burden of cancer, the development of novel therapies, and the COVID-19 pandemic have made cancer care more complex. Digital innovation was then pushed toward developing platforms to facilitate access to cancer care. Age,
Externí odkaz:
https://doaj.org/article/00acd5ac1cd74c8bb41c30f3c9c61714
Autor:
Trump, Donald L.
Publikováno v:
In Urologic Oncology: Seminars and Original Investigations 2005 23(5):381-382
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Interdisciplinary Neurosurgery, Vol 33, Iss , Pp 101760- (2023)
Originally recognized by German pathologist Frederick von Recklinghausen in 1882, neurofibromatosis type I (NF1) is an autosomal dominant disease generated from pathogenic mutation in the NF gene on chromosome 17q11.2 that affects approximately 1 in
Externí odkaz:
https://doaj.org/article/7548809f3eee4673b952d48e0d547690
Autor:
Mountzios, Giannis, Planchard, David, Metro, Giulio, Tsiouda, Dora, Prelaj, Arsela, Lampaki, Sofia, Shalata, Walid, Riudavets, Mariona, Christopoulos, Petros, Girard, Nicolas, Albarrán-Artahona, Víctor, Garcia Campelo, Rosario, Samitas, Konstantinos, Banna, Giuseppe Luigi, Boukovinas, Ioannis, Agbarya, Abed, Koumarianou, Anna, Perdikouri, Eleni-Isidora, Kosmidis, Paris, Linardou, Helena, Mauri, David, Mavroudis, Dimitrios, Athanasiadis, Ilias, Kalofonos, Haralambos, Xenidis, Nikolaos, Korantzis, Ippokratis, Ardavanis, Alexandros, Rallis, Grigorios, Bottiglieri, Achille, Efthymiadis, Konstantinos, Oikonomopoulos, Georgios, Kokkalis, Alexandros, Saloustros, Emmanouil, Tsoukalas, Nikolaos, Bartzi, Dimitra, Economopoulou, Panagiota, Psyrri, Amanda, Reck, Martin, Lo Russo, Giuseppe
Publikováno v:
In JTO Clinical and Research Reports January 2023 4(1)
Autor:
Stefania Kokkali, Emmanouil Saloustros, Dimitra Stefanou, Paris Makrantonakis, Nikolaos Kentepozidis, Ioannis Boukovinas, Nikolaos Xenidis, Panagiotis Katsaounis, Alexandros Ardavanis, Nikolaos Ziras, Athina Christopoulou, George Rigas, Kostas Kalbakis, Nikolaos Vardakis, Christos Emmanouilides, Ilias Athanasiadis, Athanassios Anagnostopoulos, Dora Hatzidaki, Efthimios Prinarakis, Foteini Simopoulou, Athanasios Kotsakis, Vassilis Georgoulias
Publikováno v:
Current Oncology, Vol 29, Iss 2, Pp 1237-1251 (2022)
Front-line bevacizumab (BEV) in combination with taxanes offers benefit in progression-free survival (PFS) in metastatic breast cancer (mBC). The medical records of mBC patients, treated with front-line BEV-based chemotherapy, were retrospectively re
Externí odkaz:
https://doaj.org/article/c982903354104203bb48bb3d0972f59f
Publikováno v:
Brodogradnja, Vol 73, Iss 4, Pp 1-11 (2022)
Installation of jacket platforms requires simultaneous and combined operations of multiple assets. Once the whole process has to be planned, it is necessary to predict in a fast and reliable way the possible weather limitations that may occur during
Externí odkaz:
https://doaj.org/article/071404c224df4a1bb3552d6d00ddb330
Autor:
Giannis Mountzios, MD, PhD, David Planchard, MD, PhD, Giulio Metro, MD, PhD, Dora Tsiouda, Arsela Prelaj, MD, Sofia Lampaki, MD, PhD, Walid Shalata, MD, Mariona Riudavets, Petros Christopoulos, MD, PhD, Nicolas Girard, MD, PhD, Víctor Albarrán-Artahona, Rosario Garcia Campelo, MD, PhD, Konstantinos Samitas, MD, PhD, Giuseppe Luigi Banna, MD, Ioannis Boukovinas, MD, PhD, Abed Agbarya, MD, PhD, Anna Koumarianou, MD, Eleni-Isidora Perdikouri, Paris Kosmidis, Helena Linardou, MD, PhD, David Mauri, MD, PhD, Dimitrios Mavroudis, MD, PhD, Ilias Athanasiadis, MD, PhD, Haralambos Kalofonos, Nikolaos Xenidis, MD, PhD, Ippokratis Korantzis, MD, Alexandros Ardavanis, Grigorios Rallis, MD, Achille Bottiglieri, Konstantinos Efthymiadis, MD, Georgios Oikonomopoulos, MD, Alexandros Kokkalis, MD, Emmanouil Saloustros, MD, PhD, Nikolaos Tsoukalas, MD, Dimitra Bartzi, MD, Panagiota Economopoulou, Amanda Psyrri, MD, PhD, Martin Reck, Giuseppe Lo Russo, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 1, Pp 100433- (2023)
Introduction: Real-world evidence regarding molecular epidemiology and management patterns of patients with EGFR exon-20 mutated, advanced NSCLC outside the context of clinical trials is lacking. Methods: We created a European registry for patients w
Externí odkaz:
https://doaj.org/article/1da16fe8f3c8428eb04732eb21d2f835